AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 19.500
  • +0.190+0.98%
20min DelayMarket Closed Jun 14 16:00 AET
2.53BMarket Cap16.24P/E (Static)

Neuren Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(Q4)Dec 30, 2023
(FY)Dec 30, 2022
(Q4)Dec 30, 2022
(FY)Dec 30, 2021
(Q4)Dec 30, 2021
(FY)Dec 30, 2020
(Q4)Dec 30, 2020
(FY)Dec 30, 2019
(Q4)Dec 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments
468.79%228.54M
468.79%228.54M
9.24%40.18M
9.24%40.18M
52.07%36.78M
52.07%36.78M
74.72%24.19M
74.72%24.19M
-41.28%13.84M
-41.28%13.84M
-Cash and cash equivalents
-57.46%17.09M
-57.46%17.09M
9.24%40.18M
9.24%40.18M
52.07%36.78M
52.07%36.78M
74.72%24.19M
74.72%24.19M
-41.28%13.84M
-41.28%13.84M
-Accounts receivable
----
----
----
----
--7K
--7K
----
----
-96.93%13K
-96.93%13K
-Other receivables
280.97%2.74M
280.97%2.74M
29.03%720K
29.03%720K
-4.78%558K
-4.78%558K
167.58%586K
167.58%586K
-65.67%219K
-65.67%219K
Total current assets
471.51%247.16M
471.51%247.16M
8.00%43.25M
8.00%43.25M
60.54%40.04M
60.54%40.04M
73.26%24.94M
73.26%24.94M
-45.96%14.4M
-45.96%14.4M
Non current assets
Non current note receivables
--771K
--771K
----
----
----
----
----
----
----
----
Regulatory assets
1,223.42%14.41M
1,223.42%14.41M
-23.53%1.09M
-23.53%1.09M
88.61%1.42M
88.61%1.42M
36.78%755K
36.78%755K
-41.40%552K
-41.40%552K
Liabilities
Current liabilities
-accounts payable
161.63%675K
161.63%675K
5.31%258K
5.31%258K
46.71%245K
46.71%245K
-50.88%167K
-50.88%167K
-74.53%340K
-74.53%340K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Current provisions
218.00%2.23M
218.00%2.23M
--700K
--700K
----
----
----
----
----
----
Current deferred liabilities
--37.12M
--37.12M
----
----
----
----
----
----
----
----
Current liabilities
2,448.45%42.76M
2,448.45%42.76M
108.97%1.68M
108.97%1.68M
6.64%803K
6.64%803K
34.70%753K
34.70%753K
-71.67%559K
-71.67%559K
Non current liabilities
Non current accrued expenses
104.76%43K
104.76%43K
75.00%21K
75.00%21K
20.00%12K
20.00%12K
0.00%10K
0.00%10K
400.00%10K
400.00%10K
Total non current liabilities
2,448.45%42.76M
2,448.45%42.76M
108.97%1.68M
108.97%1.68M
6.64%803K
6.64%803K
34.70%753K
34.70%753K
-71.67%559K
-71.67%559K
Shareholders'equity
Share capital
3.21%173.13M
3.21%173.13M
0.10%167.74M
0.10%167.74M
15.12%167.58M
15.12%167.58M
15.14%145.57M
15.14%145.57M
0.00%126.43M
0.00%126.43M
-common stock
3.21%173.13M
3.21%173.13M
0.10%167.74M
0.10%167.74M
15.12%167.58M
15.12%167.58M
15.14%145.57M
15.14%145.57M
0.00%126.43M
0.00%126.43M
Gains losses not affecting retained earnings
15.42%-6.31M
15.42%-6.31M
21.06%-7.46M
21.06%-7.46M
8.13%-9.45M
8.13%-9.45M
-20.95%-10.28M
-20.95%-10.28M
-0.07%-8.5M
-0.07%-8.5M
Total equity
473.12%247.97M
473.12%247.97M
8.02%43.27M
8.02%43.27M
60.53%40.06M
60.53%40.06M
73.21%24.95M
73.21%24.95M
-45.93%14.41M
-45.93%14.41M
(FY)Dec 30, 2023(Q4)Dec 30, 2023(FY)Dec 30, 2022(Q4)Dec 30, 2022(FY)Dec 30, 2021(Q4)Dec 30, 2021(FY)Dec 30, 2020(Q4)Dec 30, 2020(FY)Dec 30, 2019(Q4)Dec 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments 468.79%228.54M468.79%228.54M9.24%40.18M9.24%40.18M52.07%36.78M52.07%36.78M74.72%24.19M74.72%24.19M-41.28%13.84M-41.28%13.84M
-Cash and cash equivalents -57.46%17.09M-57.46%17.09M9.24%40.18M9.24%40.18M52.07%36.78M52.07%36.78M74.72%24.19M74.72%24.19M-41.28%13.84M-41.28%13.84M
-Accounts receivable ------------------7K--7K---------96.93%13K-96.93%13K
-Other receivables 280.97%2.74M280.97%2.74M29.03%720K29.03%720K-4.78%558K-4.78%558K167.58%586K167.58%586K-65.67%219K-65.67%219K
Total current assets 471.51%247.16M471.51%247.16M8.00%43.25M8.00%43.25M60.54%40.04M60.54%40.04M73.26%24.94M73.26%24.94M-45.96%14.4M-45.96%14.4M
Non current assets
Non current note receivables --771K--771K--------------------------------
Regulatory assets 1,223.42%14.41M1,223.42%14.41M-23.53%1.09M-23.53%1.09M88.61%1.42M88.61%1.42M36.78%755K36.78%755K-41.40%552K-41.40%552K
Liabilities
Current liabilities
-accounts payable 161.63%675K161.63%675K5.31%258K5.31%258K46.71%245K46.71%245K-50.88%167K-50.88%167K-74.53%340K-74.53%340K
-Total tax payable --0--0--0--0--0--0--0--0--0--0
Current provisions 218.00%2.23M218.00%2.23M--700K--700K------------------------
Current deferred liabilities --37.12M--37.12M--------------------------------
Current liabilities 2,448.45%42.76M2,448.45%42.76M108.97%1.68M108.97%1.68M6.64%803K6.64%803K34.70%753K34.70%753K-71.67%559K-71.67%559K
Non current liabilities
Non current accrued expenses 104.76%43K104.76%43K75.00%21K75.00%21K20.00%12K20.00%12K0.00%10K0.00%10K400.00%10K400.00%10K
Total non current liabilities 2,448.45%42.76M2,448.45%42.76M108.97%1.68M108.97%1.68M6.64%803K6.64%803K34.70%753K34.70%753K-71.67%559K-71.67%559K
Shareholders'equity
Share capital 3.21%173.13M3.21%173.13M0.10%167.74M0.10%167.74M15.12%167.58M15.12%167.58M15.14%145.57M15.14%145.57M0.00%126.43M0.00%126.43M
-common stock 3.21%173.13M3.21%173.13M0.10%167.74M0.10%167.74M15.12%167.58M15.12%167.58M15.14%145.57M15.14%145.57M0.00%126.43M0.00%126.43M
Gains losses not affecting retained earnings 15.42%-6.31M15.42%-6.31M21.06%-7.46M21.06%-7.46M8.13%-9.45M8.13%-9.45M-20.95%-10.28M-20.95%-10.28M-0.07%-8.5M-0.07%-8.5M
Total equity 473.12%247.97M473.12%247.97M8.02%43.27M8.02%43.27M60.53%40.06M60.53%40.06M73.21%24.95M73.21%24.95M-45.93%14.41M-45.93%14.41M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg